featured
Stereotactic Ablative Radiotherapy Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
International Journal of Radiation Oncology*Biology*Physics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Stereotactic Ablative Radiotherapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer
Int. J. Radiat. Oncol. Biol. Phys 2019 Jul 29;[EPub Ahead of Print], Y Zhang, J Schoenhals, A Christie, O Mohamad, C Wang, I Bowman, N Singla, H Hammers, K Courtney, A Bagrodia, V Margulis, N Desai, A Garant, H Choy, J Brugarolas, R Timmerman, R HannanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.